ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO 2022 on the COSMIC-313 Phase 3 Study: Cabozantinib in Combination With Nivo & Ipi for Previously Untreated Advanced RCC of IMDC Intermediate or Poor Risk
By
ecancer
FEATURING
Toni Choueiri
By
ecancer
FEATURING
Toni Choueiri
Login to view comments.
Click here to Login
